Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W, Liu B, Yan L, Du S, Vuppalapati A, Luu HH, Haydon RC, He TC, Ren G. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes and Diseases. 2018;5(2):77–106. https://doi.org/10.1016/j.gendis.2018.05.001.

Article  CAS  PubMed  Google Scholar 

Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review. Cancers. 2021;13(17):4287.

Article  PubMed  Google Scholar 

Deo SVS, Sharma J, Kumar S. GLOBOCAN 2020 report on global cancer burden: challenges and opportunities for surgical oncologists. Ann Surg Oncol. 2022;29(11):6497–500. https://doi.org/10.1245/s10434-022-12151-6.

Article  CAS  PubMed  Google Scholar 

Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20(7):745–54.

Article  CAS  PubMed  Google Scholar 

Pustylnikov S, Costabile F, Beghi S, Facciabene A. Targeting mitochondria in cancer: current concepts and immunotherapy approaches. Transl Res. 2018;202:35–51.

Article  CAS  PubMed  Google Scholar 

Munkácsy G, Santarpia L, Győrffy B. Gene expression profiling in early breast cancer—patient stratification based on molecular and tumor microenvironment features. Biomedicines. 2022;10(2):248.

Article  PubMed  Google Scholar 

Sarhadi VK, Armengol G. Molecular biomarkers in cancer Biomolecules. 2022;12(8):1021.

CAS  PubMed  Google Scholar 

https://www.ncbi.nlm.nih.gov/gene/4719

https://www.genecards.org/cgi-bin/carddisp.pl?gene=NDUFS1

Su CY, Chang YC, Yang CJ, Huang MS, Hsiao M. The opposite prognostic effect of NDUFS1 and NDUFS8 in lung cancer reflects the oncojanus role of mitochondrial complex I. Sci Rep. 2016;6(1):31357.

Article  ADS  CAS  PubMed  Google Scholar 

Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T, Zare P. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Communication and Signaling. 2020;18:1–19.

Article  Google Scholar 

Wang K, Li L, Fu L, Yuan Y, Dai H, Zhu T, Zhou Y, Yuan F. Integrated bioinformatics analysis the function of RNA binding proteins (RBPs) and their prognostic value in breast cancer. Front Pharmacol. 2019;10:140.

Article  CAS  PubMed  Google Scholar 

Calvo SE, Clauser KR, Mootha VK. MitoCarta2. 0: an updated inventory of mammalian mitochondrial proteins. Nucleic Acids Res. 2016;44(D1):D1251–7.

Article  CAS  PubMed  Google Scholar 

Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham TJ, Mootha VK. MitoCarta3. 0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 2021;49(D1):D1541–7.

Article  CAS  PubMed  Google Scholar 

Zhang Q, Liang Z, Gao Y, Teng M, Niu L. Differentially expressed mitochondrial genes in breast cancer cells: potential new targets for anti-cancer therapies. Gene. 2017;596:45–52.

Article  CAS  PubMed  Google Scholar 

Paizula X, Mutailipu D, Xu W, Wang H, Long Y. Identification of biomarkers related to tumorigenesis and prognosis in breast cancer. Gland Surg. 2022;11(9):1472–88. https://doi.org/10.21037/gs-22-449.

Article  PubMed  Google Scholar 

Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–13.

Article  CAS  PubMed  Google Scholar 

Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Von Mering C. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(D1):D447–52.

Article  CAS  PubMed  Google Scholar 

Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape stringApp: network analysis and visualization of proteomics data. J Proteome Res. 2018;18(2):623–32.

Article  PubMed  Google Scholar 

Pathan M, Keerthikumar S, Chisanga D, Alessandro R, Ang CS, Askenase P, Mathivanan S. A novel community driven software for functional enrichment analysis of extracellular vesicles data. J extracell vesicles. 2017;6(1):1321455.

Article  PubMed  Google Scholar 

Benito-Martin A, Peinado H. FunRich proteomics software analysis, let the fun begin! Proteomics. 2015;15(15):2555–6.

Article  CAS  PubMed  Google Scholar 

Liu Z, Zhou J, Wang Z, Zhou Z. Analysis of SEC24D gene in breast cancer based on UALCAN database. Open Life Sci. 2019;31(14):707–11. https://doi.org/10.1515/biol-2019-0080.PMID:33817210;PMCID:PMC7874789.

Article  Google Scholar 

Sudha B, Poornima A, Suganya K, Swathi K, Kumar NS, Sumathi S, Chellapandi P. Identification of hub genes and role of CDKN2A as a biomarker in cervical cancer: an in-silico approach. Human Gene. 2022;33: 201048.

Article  CAS  Google Scholar 

Lin R-H, Lin C-S, Chuang C-L, Kujabi BK, Chen Y-C. Breast Cancer Survival Analysis Model. Appl Sci. 2022;12(4):1971. https://doi.org/10.3390/app12041971. (MDPI AG).

Article  CAS  Google Scholar 

Zhu C, Menyhárt O, Győrffy B, He X. The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy. BMC Cancer. 2019;19(1):1–12. https://doi.org/10.1186/s12885-019-6260-6.

Article  CAS  Google Scholar 

Mei J, Liu Y, Xu R, Hao L, Qin A, Chu C, Zhu Y, Liu X. Characterization of the expression and prognostic value of 14–3–3 isoforms in breast cancer. Aging (Albany NY). 2020 Oct 14;12(19):19597–19617. doi: https://doi.org/10.18632/aging.103919. Epub 2020 Oct 14. Erratum in: Aging (Albany NY). 2022 Aug 30;14(16):6840–6841. PMID: 33052135; PMCID: PMC7732302.

Zhou Q, Liu X, Lv M, Sun E, Lu X, Lu C. Genes that predict poor prognosis in breast cancer via bioinformatical analysis. Biomed Res Int. 2021;17(2021):6649660. https://doi.org/10.1155/2021/6649660. (PMID:33959662;PMCID:PMC8075678).

Article  CAS  Google Scholar 

Suganya K, Sudha B, Poornima A, Senthil Kumar N, Sumathi S. Reduced expression of SFRP1 is associated with poor prognosis and promotes cell proliferation in breast cancer: an integrated bioinformatics approach. Indian J Gynecol Oncol. 2022;20(4):46.

Article  Google Scholar 

Győrffy B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J. 2021;19:4101–9.

Article  PubMed  Google Scholar 

Ye H, Zhang N. Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer. Computational and Mathematical Methods in Medicine, 2021. 2021

Wallace DC. Mitochondria and cancer. Nat Rev Cancer. 2012;12(10):685–98.

Article  CAS  PubMed  Google Scholar 

Klæstad E, Opdahl S, Engstrøm MJ, Ytterhus B, Wik E, Bofin AM, Valla M. MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes. Breast Cancer Res Treat. 2020;180:73–86.

Article  PubMed  Google Scholar 

Wiebringhaus R, Pecoraro M, Neubauer HA, Trachtová K, Trimmel B, Wieselberg M, Kenner L. Proteomic analysis identifies NDUFS1 and ATP5O as novel markers for survival outcome in prostate cancer. Cancers. 2021;13(23):6036.

Article  CAS  PubMed  Google Scholar 

Xu H, Zou R, Li F, Liu J, Luan N, Wang S, Zhu L. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer. Cancer Med. 2021;10(11):3655–73.

Article  CAS  PubMed  Google Scholar 

Qiu X, Guo D, Du J, Bai Y, Wang F. A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidate. Medicine. 2021;100(8):e24898.

Article  CAS  PubMed  Google Scholar 

Jiang W, Zhang C, Kang Y, Yu X, Pang P, Li G, Feng Y. MRPL42 is activated by YY1 to promote lung adenocarcinoma progression. J Cancer. 2021;12(8):2403.

Article  CAS  PubMed  Google Scholar 

Zhuang L, Meng Z, Yang Z. MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients. Int J Med Sci. 2021;18(4):936.

Article  CAS  PubMed  Google Scholar